Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K M Shokat

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|April 15, 1997
Engineering unnatural nucleotide specificity for Rous sarcoma virus tyrosine kinase to uniquely label its direct substratesK Shah, Y Liu, C Deirmengian, et al.
Annual Review of Cell and Developmental Biology|November 1, 2001
Recent advances in chemical approaches to the study of biological systemsM A Shogren-Knaak, P J Alaimo, K M Shokat
Current Opinion in Chemical Biology|July 27, 2001
Chemical genetic approaches for the elucidation of signaling pathwaysP J Alaimo, M A Shogren-Knaak, K M Shokat
Bioorganic & Medicinal Chemistry|October 24, 1998
A molecular gate which controls unnatural ATP analogue recognition by the tyrosine kinase v-SrcY Liu, K Shah, F Yang, et al.
Chemistry & Biology|March 13, 1998
Engineering Src family protein kinases with unnatural nucleotide specificityY Liu, K Shah, F Yang, et al.
Nature Cell Biology|October 12, 2000
Chemical genetic analysis of the budding-yeast p21-activated kinase Cla4pE L Weiss, A C Bishop, K M Shokat, et al.
Biochemistry|November 23, 2000
Src-Abl tyrosine kinase chimeras: replacement of the adenine binding pocket of c-Abl with v-Src to swap nucleotide and inhibitor specificitiesY Liu, L A Witucki, K Shah, et al.
Analytical Biochemistry|January 16, 1999
Highly efficient green fluorescent protein-based kinase substratesF Yang, Y Liu, S D Bixby, et al.
Current Biology : CB|April 16, 1998
Design of allele-specific inhibitors to probe protein kinase signalingA C Bishop, K Shah, Y Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 27, 2004
Sole BCR-ABL inhibition is insufficient to eliminate all myeloproliferative disorder cell populationsS Wong, J McLaughlin, D Cheng, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Proceedings of the National Academy of Sciences of the United States of America|April 15, 1997
Engineering unnatural nucleotide specificity for Rous sarcoma virus tyrosine kinase to uniquely label its direct substratesK Shah, Y Liu, C Deirmengian, et al.
Annual Review of Cell and Developmental Biology|November 1, 2001
Recent advances in chemical approaches to the study of biological systemsM A Shogren-Knaak, P J Alaimo, K M Shokat
Current Opinion in Chemical Biology|July 27, 2001
Chemical genetic approaches for the elucidation of signaling pathwaysP J Alaimo, M A Shogren-Knaak, K M Shokat
Bioorganic & Medicinal Chemistry|October 24, 1998
A molecular gate which controls unnatural ATP analogue recognition by the tyrosine kinase v-SrcY Liu, K Shah, F Yang, et al.
Chemistry & Biology|March 13, 1998
Engineering Src family protein kinases with unnatural nucleotide specificityY Liu, K Shah, F Yang, et al.
Nature Cell Biology|October 12, 2000
Chemical genetic analysis of the budding-yeast p21-activated kinase Cla4pE L Weiss, A C Bishop, K M Shokat, et al.
Biochemistry|November 23, 2000
Src-Abl tyrosine kinase chimeras: replacement of the adenine binding pocket of c-Abl with v-Src to swap nucleotide and inhibitor specificitiesY Liu, L A Witucki, K Shah, et al.
Analytical Biochemistry|January 16, 1999
Highly efficient green fluorescent protein-based kinase substratesF Yang, Y Liu, S D Bixby, et al.
Current Biology : CB|April 16, 1998
Design of allele-specific inhibitors to probe protein kinase signalingA C Bishop, K Shah, Y Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 27, 2004
Sole BCR-ABL inhibition is insufficient to eliminate all myeloproliferative disorder cell populationsS Wong, J McLaughlin, D Cheng, et al.
Pageof 4